Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.

Become a member

Healixia events

  1. Traject - website bij events.jpg
    14 October '20

    Healixia's journey - Let's connect

    We invite you to our Healixia's journey - let's connect: multiple webinars from our 4 domains: whenever and wherever you want!

  2. Online sessie2.jpg
    22 October '20

    CTR Session (online)

    On the agenda:

    • Implementation CTR EU and national 
    • EU PD Portal: status update 
    • Future training 
    • Role of the College and ethics committee
    • Pilot projects with reflections from:
      • FAMHP
      • Academic sponsors
      • Industry
  3. medical.png
    27 November '20

    The evolving role in Medical affairs: our increasing role in market access (online)

    With Patricia van Dijck - Market Access & Public Affairs Director at GSK Belux

Show all meetings

News

  1. September 29, 2020

    Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages

    Source: FAMHP

    On 1 April 2020, the FAMHP took steps regarding a range of medicinal products in order to avoid any shortage. These measures have now been extended by one month.

    Read more

  2. September 29, 2020

    Give your opinion on a genetically modified drug for the treatment of Duchenne muscular dystrophy

    Source: FAMHP

    The FPS Public Health and FAMHP would like to invite you to take part in the public consultation on a clinical trial testing the genetically modified drug PF-06939926 for the treatment of Duchenne muscular dystrophy. The public consultation will run from 23 September 2020 to 23 October 2020.

    Read more

  3. September 29, 2020

    Coronavirus: at-home antibody tests are no longer banned, but the FAMHP warns against misinterpreting the result

    Source: FAMHP

    The sale of at-home tests detecting antibodies against the new coronavirus (SARS-CoV-2) will no longer be prohibited as of 19 September 2020. However, the FAMHP warns users that there are still significant reservations about the accuracy of both negative and positive results. These at-home tests may give users a false sense of security or cause them unnecessary anxiety.

    Read more

We thank our partners for their support. Click on the logos for more information:
jsn_logo_jj_vert_color_rgb.jpgdigidyco_clinical esolutions_gr_web2.png  keyrus_life_science_logo_HD-WEB.png   Modis 440x320 nieuwsbrief.jpg logo Hebias web.png